z-logo
open-access-imgOpen Access
Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis
Author(s) -
Michael B. Stokes,
Kirk Foster,
Glen S. Markowitz,
Farhang Ebrahimi,
William H. Hines,
Darren Kaufman,
Brooke Moore,
Daniel J. Wolde,
Vivette D. D’Agati
Publication year - 2005
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh832
Subject(s) - medicine , rheumatoid arthritis , glomerulonephritis , tumor necrosis factor alpha , immunology , kidney
Treatment of rheumatoid arthritis with anti-tumour necrosis factor alpha (TNFalpha) agents may lead to autoantibody formation and flares of vasculitis, but renal complications are rare.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom